Gene · 4205
Papers4,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A New linc(-RNA) Between NFAT/MEF2 and Cardiac Hypertrophy. | Circ Res | 2024 | 39024397 | PubTator, text mining | PubMed |
| The Molecular and Biological Function of MEF2D in Leukemia. | Adv Exp Med Biol | 2024 | 39017853 | PubTator, text mining | PubMed |
| Functional analysis of protein interactions using coupled bi-fluorescence complementation/GFP nanobody techniques. | Nucleic Acids Res | 2024 | 38932691 | PubTator, text mining | PubMed |
| NOVEL ACTIVE PROTEINS FOR SEPSIS PROGNOSIS REVEALED THROUGH ScRNA-seq AND QUANTITATIVE PROTEOMICS. | Shock | 2024 | 38888471 | PubTator, text mining | PubMed |
| Cardiac Transcription Factors and Regulatory Networks. | Adv Exp Med Biol | 2024 | 38884718 | PubTator, text mining | PubMed |
| Identifying unstable CNG repeat loci in the human genome: a heuristic approach and implications for neurological disorders. | Hum Genome Var | 2024 | 38871700 | PubTator, text mining | PubMed |
| Identifying the regulatory network of microRNAs and mRNAs to clarify molecular mechanisms in stroke by bioinformatics analysis. | Technol Health Care | 2024 | 38848199 | PubTator, text mining | PubMed |
| Circulating miRNA-4701-3p as a predictive biomarker of cardiovascular disease which induces angiogenesis by inhibition of TOB2. | Microvasc Res | 2024 | 38801943 | PubTator, text mining | PubMed |
| MEF2D Functions as a Tumor Suppressor in Breast Cancer. | Int J Mol Sci | 2024 | 38791246 | PubTator, text mining | PubMed |
| Retraction for Lv et al., ABHD5 protects cardiac function in alcoholic cardiomyopathy via HDAC4-NT to inhibit CAMKII/MEF2 axis. | J Appl Physiol (1985) | 2024 | 38743613 | PubTator, text mining | PubMed |
| Stem-Cell-Driven Chondrogenesis: Perspectives on Amnion-Derived Cells. | Cells | 2024 | 38727280 | PubTator, text mining | PubMed |
| Cellular remodeling and JAK inhibition promote zygotic gene expression in the Ciona germline. | EMBO Rep | 2024 | 38649664 | PubTator, text mining | PubMed |
| Resveratrol-Based Liposomes Improve Cardiac Remodeling Induced by Isoproterenol Partially by Modulating MEF2, Cytochrome C and S100A1 Expression. | Dose Response | 2024 | 38645382 | PubTator, text mining | PubMed |
| Folding of Class IIa HDAC Derived Peptides into α-helices Upon Binding to Myocyte Enhancer Factor-2 in Complex with DNA. | J Mol Biol | 2024 | 38492719 | PubTator, text mining | PubMed |
| Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation. | Cells | 2024 | 38474384 | PubTator, text mining | PubMed |
| Identifying key antioxidative stress factors regulating Nrf2 in the genioglossus with human umbilical cord mesenchymal stem-cell therapy. | Sci Rep | 2024 | 38462642 | PubTator, text mining | PubMed |
| A Study of transcription factor MEF2A gene polymorphisms in patients with coronary artery disease. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38372109 | PubTator, text mining | PubMed |
| DNA-Diffusion: Leveraging Generative Models for Controlling Chromatin Accessibility and Gene Expression via Synthetic Regulatory Elements. | bioRxiv | 2024 | 38352499 | PubTator, text mining | PubMed |
| IP3R1-mediated MAMs formation contributes to mechanical trauma-induced hepatic injury and the protective effect of melatonin. | Cell Mol Biol Lett | 2024 | 38308199 | PubTator, text mining | PubMed |
| Targeting histone deacetylase 9 represses fibrogenic phenotypes in buccal mucosal fibroblasts with arecoline stimulation. | J Dent Sci | 2024 | 38303807 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4205/papers?page=8